ENTEROBIOTIX LIMITED

Company number SC559230

Date	Type	Description	View / Download
08 Jan 2020	TM01	Termination of appointment of Colin Christopher Bennett as a director on 30 December 2019	(1 page)
08 Jan 2020	AP01	Appointment of Mr Mark Bamforth as a director on 30 December 2019	(2 pages)
08 Jan 2020	AP01	Appointment of Mr Iain Baird as a director on 30 December 2019	(2 pages)
08 Jan 2020	AP01	Appointment of Mr Douglas Campbell Thomson as a director on 30 December 2019	(2 pages)
11 Sep 2019	AP01	Appointment of Mr Michael Butler as a director on 11 September 2019	(2 pages)
01 Aug 2019	TM01	Termination of appointment of Gavin David Clark as a director on 13 June 2019	(1 page)
31 Jul 2019	TM01	Termination of appointment of James Scott Clark as a director on 31 July 2019	(1 page)
03 Jul 2019	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of Memorandum and/or Articles of Association	(1 page)
29 May 2019	MA	Memorandum and Articles of Association	(29 pages)
27 May 2019	SH01	Statement of capital following an allotment of shares on 23 May 2019 GBP 962.407	(3 pages)
19 Apr 2019	CS01	Confirmation statement made on 19 April 2019 with updates	(11 pages)
19 Apr 2019	SH01	Statement of capital following an allotment of shares on 15 March 2019 GBP 912.074	(3 pages)
29 Mar 2019	CS01	Confirmation statement made on 28 March 2019 with updates	(10 pages)
25 Mar 2019	SH01	Statement of capital following an allotment of shares on 15 March 2019 GBP 912.54	(3 pages)
05 Dec 2018	CH01	Director's details changed for Professor Sir Lewis Duthie Ritchie on 4 December 2018	(2 pages)
04 Dec 2018	AP01	Appointment of Ms Carol Joyce Scambler as a director on 5 October 2018	(2 pages)
04 Dec 2018	CH01	Director's details changed for Dr James Scott Clark on 4 December 2018	(2 pages)
04 Dec 2018	TM01	Termination of appointment of Andrew Alan Coleman as a director on 5 October 2018	(1 page)
09 Nov 2018	AA	Unaudited abridged accounts made up to 31 March 2018	(11 pages) Download iXBRL
13 Sep 2018	SH01	Statement of capital following an allotment of shares on 28 August 2018 GBP 833.286	(3 pages)
11 Sep 2018	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(29 pages)
06 Aug 2018	AD01	Registered office address changed from PO Box AB25 2ZW Aberdeen & North East Scotland Blood Transfusion C Foresterhill Road Foresterhill Aberdeen Aberdeenshire AB25 2ZW United Kingdom to Aberdeen & North East Blood Transfusion Centre Foresterhill Road Aberdeen Aberdeenshire AB25 2ZW on 6 August 2018	(1 page)
20 Apr 2018	AD01	Registered office address changed from Citypoint 65 Haymarket Terrace Edinburgh EH12 5HD Scotland to PO Box AB25 2ZW Aberdeen & North East Scotland Blood Transfusion C Foresterhill Road Foresterhill Aberdeen Aberdeenshire AB25 2ZW on 20 April 2018	(1 page)
12 Mar 2018	CS01	Confirmation statement made on 1 March 2018 with updates	(6 pages)
12 Mar 2018	SH01	Statement of capital following an allotment of shares on 14 July 2017 GBP 627.107	(3 pages)